Treated MI‐induced heart failure (HF) rats with either tyrosine phosphorylation‐regulated kinase 1A (Dyrk1A) inhibitor or EGCG improved the HF symptoms and reversed the molecular changes of Dyrk1A 23. This evidence concerns the gene DYRK1A and heart failure.